FrançaisNovacyt revenues full year 2018 Paris, France and Camberley, UK – 22 January 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited revenues for the full year ended 31 December 2018.
Visit PageCategory: Uncategorized
Novacyt Trading Update
Novacyt trading update Paris, France and Camberley, UK – 24 December 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics products, on the 11 December announced its decision to sell the NOVAprep® business unit. As a result, the Company confirms that NOVAprep® will be treated as a discontinued operation under
Visit PageNovacyt launches two new CE-IVD Marked molecular diagnostic kits
Novacyt launches two new molecular CE Mark assays First of an expanding menu of tests for monitoring post-transplantation and immunosuppressed patients
Visit Page